Screener Summaries Updates Institutions Sign In More Updates › Mergers & Acquisitions › VYNE Mergers & Acquisitions · Jul 14, 2026
VYNE Therapeutics Inc. published an investor presentation on July 14, 2026, regarding a proposed transaction between… VYNE Yarrow Bioscience, Inc.
VYNE Therapeutics Inc. published an investor presentation on July 14, 2026, regarding a proposed transaction between VYNE and Yarrow Bioscience, Inc. The presentation is intended for investor relations and is accompanied by an attached Exhibit 99.1. VYNE Therapeutics Inc. operates in the biotechnology/pharmaceutical industry and develops therapeutic solutions for various medical conditions.
More from Yarrow Bioscience, Inc. Yarrow Bioscience, Inc. entered into an underwriting agreement on September 10, 2026, to sell 5,769,231 shares of… Sep 14, 2026 Yarrow Bioscience, Inc. entered into an exchange agreement with an existing stockholder to swap 133,290 shares of… Jul 30, 2026 Yarrow Bioscience, Inc. (formerly VYNE Therapeutics) completed its merger with Pre-Merger Yarrow on July 27, 2026… Jul 28, 2026 VYNE Therapeutics announced a 1-for-50 reverse stock split and a special cash dividend of approximately $0.40242 per… Jul 21, 2026 VYNE Therapeutics Inc. held a special meeting on July 16, 2026, where stockholders approved several key proposals… Jul 17, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
